A. Le-rhumatisme, 40 2.2.1 La SpA axiale, p.41

H. De-gastroentérologie-et-de-rhumatologie and .. , 47 A. Évaluation d'un outil de dépistage des spondyloarthrites chez des patients atteints de maladie inflammatoire chronique de l'intestin, p.47

I. Bibliographie, N. Molodecky, I. Soon, and D. Rabi, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) Epidemiology of inflammatory bowel diseases from west to east, Gastroenterology Gut J Dig Dis, vol.1423, issue.18, pp.46-54, 1996.

D. Franchimont and E. Louis, Genetics of inflammatory bowel disease

C. Anderson, G. Boucher, and C. Lees, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nature Genetics, vol.38, issue.3, pp.246-252, 2011.
DOI : 10.1046/j.1365-2036.2001.00981.x

J. Cosnes, F. Carbonnel, and F. Carrat, Effects of current and former cigarette smoking on the clinical course of Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.30, issue.11, pp.1403-1411, 1999.
DOI : 10.1001/archinte.157.12.1371

B. Calkins, A meta-analysis of the role of smoking in inflammatory bowel disease, Digestive Diseases and Sciences, vol.284, issue.12
DOI : 10.1007/BF01536701

S. Mahid, K. Minor, and R. Soto, Smoking and Inflammatory Bowel Disease: A Meta-analysis, Mayo Clinic Proceedings, vol.81, issue.11, pp.1462-1471, 2002.
DOI : 10.4065/81.11.1462

K. Forrest, D. Symmons, and P. Foster, Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?, Alimentary Pharmacology and Therapeutics, vol.125, issue.10, pp.1035-1043, 2004.
DOI : 10.1046/j.1365-2036.2003.01596.x

A. Ananthakrishnan, L. Higuchi, and E. Huang, Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis, Annals of Internal Medicine, vol.156, issue.5, pp.350-359, 2012.
DOI : 10.7326/0003-4819-156-5-201203060-00007

J. Cornish, E. Tan, and C. Simillis, The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis, The American Journal of Gastroenterology, vol.316, issue.6 Suppl, pp.2394-2400, 2008.
DOI : 10.1136/bmj.316.7124.61

M. Kronman, T. Zaoutis, and K. Haynes, Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study, PEDIATRICS, vol.130, issue.4, pp.794-803, 2012.
DOI : 10.1542/peds.2011-3886

URL : http://pediatrics.aappublications.org/content/pediatrics/130/4/e794.full.pdf

E. Lane, T. Zisman, and D. Suskind, The microbiota in inflammatory bowel disease: current and therapeutic insights, Journal of Inflammation Research, vol.10, pp.63-73, 2017.
DOI : 10.2147/JIR.S116088

R. Colman and D. Rubin, Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis, Journal of Crohn's and Colitis, vol.48, issue.12, pp.1569-1581, 2014.
DOI : 10.1097/MCG.0000000000000046

URL : https://academic.oup.com/ecco-jcc/article-pdf/8/12/1569/8734747/8-12-1569.pdf

E. Louis, A. Collard, and A. Oger, Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease, Gut, vol.49, issue.6, pp.777-782, 2001.
DOI : 10.1136/gut.49.6.777

J. Satsangi, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-753, 2006.
DOI : 10.1136/gut.2005.082909

D. Esser, F. Cornillie, and R. Diamond, On the updated ECCO consensus guidelines for medical management of Crohn's disease, Journal of Crohn's and Colitis, vol.350, issue.Suppl 1, pp.165-166, 2011.
DOI : 10.1056/NEJMoa030815

C. Solem, E. Loftus, and W. Tremaine, Correlation of C-Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.128, issue.8
DOI : 10.1097/01.CRD.0000077906.74217.6E

F. Costa, M. Mumolo, and M. Bellini, Role of faecal calprotectin as non-invasive marker of intestinal inflammation, Digestive and Liver Disease, vol.35, issue.9, pp.642-647, 2003.
DOI : 10.1016/S1590-8658(03)00381-5

T. Sipponen, P. Kärkkäinen, and E. Savilahti, Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn???s disease and histological findings, Alimentary Pharmacology & Therapeutics, vol.95, issue.10, pp.1221-1229, 2008.
DOI : 10.1016/0016-5085(90)90613-6

P. Gionchetti, F. Rizzello, and V. Annese, Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease, Digestive and Liver Disease, vol.49, issue.6, pp.604-617, 2017.
DOI : 10.1016/j.dld.2017.01.161

J. Park, S. Yang, and B. Ye, Second Korean Guidelines for the Management of Crohn's Disease, The Korean Journal of Gastroenterology, vol.69, issue.1, pp.29-54, 2017.
DOI : 10.4166/kjg.2017.69.1.29

L. Peyrin-biroulet, Algorithmes de prise en charge de la maladie de Crohn en 2016 : Consensus National Francais

W. Best, J. Becktel, and J. Singleton, Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study, Gastroenterology, vol.70, pp.439-444, 1976.

R. Harvey and J. Bradshaw, A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY, The Lancet, vol.315, issue.8167, p.514, 1980.
DOI : 10.1016/S0140-6736(80)92767-1

P. Rutgeerts, K. Geboes, and G. Vantrappen, Predictability of the postoperative course of Crohn's disease, Gastroenterology, vol.99, issue.4, pp.956-963, 1990.
DOI : 10.1016/0016-5085(90)90613-6

F. Baert, L. Moortgat, and G. Van-assche, Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease, Gastroenterology, vol.138, issue.2, pp.463-468, 2010.
DOI : 10.1053/j.gastro.2009.09.056

P. Rutgeerts, R. Diamond, and M. Bala, Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease, Gastrointestinal Endoscopy, vol.63, issue.3, pp.433-442, 2006.
DOI : 10.1016/j.gie.2005.08.011

K. Frøslie, J. Jahnsen, and B. Moum, Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort, Gastroenterology, vol.133, issue.2, pp.412-422, 2007.
DOI : 10.1053/j.gastro.2007.05.051

A. Sanchez, V. , G. Rojas, P. , B. Paredes et al., Association between ulcerative colitis and primary esclerosing cholangitis], Rev Gastroenterol Peru Organo Of Soc Gastroenterol Peru, vol.36, pp.175-178, 2016.

M. Mahler, J. Damoiseaux, and V. Ballet, PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis, Clinical Chemistry and Laboratory Medicine (CCLM), vol.9, issue.1, pp.10-1515, 2017.
DOI : 10.1515/cclm-2017-0346

URL : http://www.degruyter.com/downloadpdf/j/cclm.2018.56.issue-1/cclm-2017-0346/cclm-2017-0346.xml

I. Solberg, I. Lygren, and J. Jahnsen, Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study), Scandinavian Journal of Gastroenterology, vol.19, issue.2, pp.431-440, 2009.
DOI : 10.3109/00365529609004876

A. Ekbom, C. Helmick, and M. Zack, Ulcerative Colitis and Colorectal Cancer, New England Journal of Medicine, vol.323, issue.18, pp.1228-1233, 1990.
DOI : 10.1056/NEJM199011013231802

C. Zallot and L. Peyrin-biroulet, Clinical Risk Factors for Complicated Disease: How Reliable Are They?, Digestive Diseases, vol.59, issue.s3, pp.67-72, 2012.
DOI : 10.1136/gutjnl-2011-300049

C. Choi, W. Moon, and Y. Kim, Second Korean guidelines for the management of ulcerative colitis, Intestinal Research, vol.15, issue.1, pp.7-37, 2017.
DOI : 10.5217/ir.2017.15.1.7

S. Truelove and L. Witts, Cortisone in Ulcerative Colitis, BMJ, vol.2, issue.4947, pp.1041-1048, 1955.
DOI : 10.1136/bmj.2.4947.1041

S. Vavricka, A. Schoepfer, and M. Scharl, Extraintestinal Manifestations of Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.336, issue.8, pp.1982-1992, 2015.
DOI : 10.1056/NEJM199703063361003

URL : https://hal.archives-ouvertes.fr/hal-01667949

N. Gidwaney, S. Pawa, and K. Das, Pathogenesis and clinical spectrum of primary sclerosing cholangitis, World Journal of Gastroenterology, vol.23, issue.14, pp.2459-2469, 2017.
DOI : 10.3748/wjg.v18.i1.1

B. Jaïs, P. Lévy, and J. Reimund, Pancréatites et maladies inflammatoires chroniques intestinales, pp.6-12, 2013.

A. Marzano, A. Borghi, and A. Stadnicki, Cutaneous Manifestations in Patients With Inflammatory Bowel Diseases, Inflammatory Bowel Diseases, vol.157, issue.1, pp.213-227, 2014.
DOI : 10.1111/j.1365-2133.2007.08048.x

M. Kappelman, E. Horvath-puho, and R. Sandler, Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study, Gut, vol.60, issue.7, pp.937-943, 2011.
DOI : 10.1136/gut.2010.228585

U. Monsén, J. Sorstad, and G. Hellers, Extracolonic diagnoses in ulcerative colitis: an epidemiological study, Am J Gastroenterol, vol.85, pp.711-716, 1990.

C. Salvarani, I. Vlachonikolis, and D. Van-der-heijde, Musculoskeletal Manifestations in a Population-based Cohort of Inflammatory Bowel Disease Patients, Scandinavian Journal of Gastroenterology, vol.36, issue.12, pp.1307-1313, 2001.
DOI : 10.1080/003655201317097173

M. Dougados, S. Van-der-linden, and R. Juhlin, The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy, Arthritis & Rheumatism, vol.57, issue.10, pp.1218-1227, 1991.
DOI : 10.1002/art.1780341003

?. Yüksel, H. Ataseven, and Ö. Ba?ar, Peripheral Arthritis in the Course of, Inflammatory Bowel Diseases. Dig Dis Sci, vol.56, pp.183-187, 2011.

T. Orchard, B. Wordsworth, and D. Jewell, Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history, Gut, vol.42, issue.3, pp.387-391, 1998.
DOI : 10.1136/gut.42.3.387

O. Palm, B. Moum, and A. Ongre, Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study), J Rheumatol, vol.29, pp.511-515, 2002.

T. Rodríguez-reyna, Rheumatic manifestations of in???ammatory bowel disease, World Journal of Gastroenterology, vol.15, issue.44
DOI : 10.3748/wjg.15.5517

K. De-vlam, H. Mielants, and C. Cuvelier, Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association, J Rheumatol, vol.27, pp.2860-2865, 2000.

R. Queiro, O. Maiz, and J. Intxausti, Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study, Clinical Rheumatology, vol.19, issue.6, pp.445-449, 2000.
DOI : 10.1007/s100670070003

T. Orchard, H. Holt, and L. Bradbury, The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn???s disease, Alimentary Pharmacology & Therapeutics, vol.5, issue.2, pp.193-197, 2009.
DOI : 10.1097/00054725-199905000-00004

F. Bandinelli, R. Terenzi, and L. Giovannini, Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis, Clin Exp Rheumatol, vol.32, pp.949-952, 2014.

C. Salvarani and W. Fries, Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease, World Journal of Gastroenterology, vol.15, issue.20, pp.2449-2455, 2009.
DOI : 10.3748/wjg.15.2449

D. Vos and M. , Joint Involvement Associated with Inflammatory Bowel Disease, Digestive Diseases, vol.27, issue.4, pp.511-515, 2009.
DOI : 10.1159/000233290

M. Harbord, V. Annese, and S. Vavricka, The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease, Journal of Crohn's and Colitis, vol.10, issue.3, pp.239-254, 2016.
DOI : 10.1093/ecco-jcc/jjv213

J. Naves, E. Cabré, and M. Mañosa, A Systematic Review of SAPHO Syndrome and Inflammatory Bowel Disease Association, Digestive Diseases and Sciences, vol.37, issue.8, pp.2138-2147, 2013.
DOI : 10.3899/jrheum.091086

K. Siau and C. Laversuch, SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate, Joint Bone Spine, vol.77, issue.2, pp.176-177, 2010.
DOI : 10.1016/j.jbspin.2009.05.017

URL : https://hal.archives-ouvertes.fr/hal-00568300

J. Crone, W. Huber, and R. Resch, Hypertrophic Osteoarthropathy in Untreated Ulcerative Colitis, Journal of Pediatric Gastroenterology and Nutrition, vol.35, issue.2, pp.213-215, 2002.
DOI : 10.1097/00005176-200208000-00021

URL : http://pdfs.journals.lww.com/jpgn/2002/08000/Hypertrophic_Osteoarthropathy_in_Untreated.21.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503062658268;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdLSp5vhs7zG9m2iHH5FnhdsI45GsgNpe1huDLmQenoBo=;hash|LcHF0mpdA2ZPG2S+1OjuPQ==

Y. Shim and J. Suh, Primary hypertrophic osteoarthropathy accompanied by Crohn's disease: a case report, Yonsei Medical Journal, vol.38, issue.5, pp.319-322, 1997.
DOI : 10.3349/ymj.1997.38.5.319

E. Masson, Ostéo-arthropathie hypertrophiante secondaire : (syndrome de Pierre

. Marie-bamberger, EM-Consultehttp://www.em-consulte.com/article/8264/osteo- arthropathie-hypertrophiante-secondaire-synd (accessed 1, 2016.

A. Herneth, M. Breitenseher, and M. Funovics, Quiz case 12, European Journal of Radiology, vol.32, issue.2, pp.124-128, 1999.
DOI : 10.1016/S0720-048X(99)00095-9

Ø. Palm, T. Bernklev, and B. Moum, Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life, J Rheumatol, vol.32, pp.1755-1759, 2005.

O. Palm, B. Moum, and J. Jahnsen, Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: a cross sectional population survey, J Rheumatol, vol.28, pp.590-594, 2001.

H. Freeman and K. Freeman, Prevalence Rates and an Evaluation of Reported Risk Factors for Osteonecrosis (Avascular Necrosis) in Crohn???s Disease, Canadian Journal of Gastroenterology, vol.14, issue.2, pp.138-143, 2000.
DOI : 10.1155/2000/958086

G. Klingenstein, R. Levy, and A. Kornbluth, Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature, Alimentary Pharmacology and Therapeutics, vol.77, issue.3, pp.243-249, 2005.
DOI : 10.1097/00003086-199603000-00020

P. Grunert, F. Collettini, and C. Perka, A Rare Cause of Peripheral Arthralgia in Inflammatory Bowel Disease: Multifocal Osteonecrosis, Zeitschrift f??r Gastroenterologie, vol.52, issue.03, pp.285-289, 2014.
DOI : 10.1055/s-0034-1365933

J. Hinojosa, J. Borrás-blasco, and N. Maroto, Severe Myalgia Associated with Adalimumab Treatment in a Patient with Crohn's Disease, Annals of Pharmacotherapy, vol.2, issue.7-8, pp.1130-1133, 2008.
DOI : 10.1038/clpt.1981.154

D. Laukens, M. Georges, and C. Libioulle, Evidence for Significant Overlap between Common Risk Variants for Crohn's Disease and Ankylosing Spondylitis, PLoS ONE, vol.27, issue.11, p.13795, 2010.
DOI : 10.1371/journal.pone.0013795.s001

URL : https://doi.org/10.1371/journal.pone.0013795

L. Van-praet, P. Jacques, and F. Van-den-bosch, The transition of acute to chronic bowel inflammation in spondyloarthritis, Nature Reviews Rheumatology, vol.70, issue.5, pp.288-295, 2012.
DOI : 10.1136/ard.2010.149229

J. Sherlock, B. Joyce-shaikh, and S. Turner, IL-23 induces spondyloarthropathy by acting on ROR-??t+ CD3+CD4???CD8??? entheseal resident T cells, Nature Medicine, vol.181, issue.7, pp.1069-1076, 2012.
DOI : 10.1089/hum.2005.16.126

M. Rudwaleit, New approaches to diagnosis and classification of axial and peripheral spondyloarthritis, Current Opinion in Rheumatology, vol.22, issue.4, pp.375-380, 2010.
DOI : 10.1097/BOR.0b013e32833ac5cc

M. Seo, H. Baek, and H. Yoon, Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis, Clinical Rheumatology, vol.31, issue.8, pp.1397-1405, 2015.
DOI : 10.1136/annrheumdis-2012-202073

M. Rudwaleit, J. Listing, and J. Brandt, Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor ?? blockers in ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.63, issue.6, pp.665-670, 2004.
DOI : 10.1136/ard.2003.016386

S. Van-der-linden, H. Valkenburg, and A. Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis, Arthritis & Rheumatism, vol.2, issue.4, pp.361-368, 1984.
DOI : 10.7326/0003-4819-84-1-1

W. Mau, H. Zeidler, and R. Mau, Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup, J Rheumatol, vol.15, pp.1109-1114, 1988.

B. Amor, M. Dougados, and V. Listrat, Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG) A crosssectional analysis of 2,228 patients], Ann Med Interne (Paris), vol.142, pp.85-89, 1991.

M. Rudwaleit, R. Landewé, and D. Van-der-heijde, The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.770-776, 2009.
DOI : 10.1136/ard.2009.108217

M. Rudwaleit, D. Van-der-heijde, and R. Landewé, The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.777-783, 2009.
DOI : 10.1136/ard.2009.108233

M. Rudwaleit, D. Van-der-heijde, and R. Landewé, The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general, Annals of the Rheumatic Diseases, vol.70, issue.1, pp.25-31, 2011.
DOI : 10.1136/ard.2010.133645

J. Sieper, M. Rudwaleit, and X. Baraliakos, The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis, Annals of the Rheumatic Diseases, vol.68, issue.Suppl 2, pp.1-44, 2009.
DOI : 10.1136/ard.2008.104018

L. Heuft-dorenbosch, A. Spoorenberg, and A. Van-tubergen, Assessment of enthesitis in ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.62, issue.2, pp.127-132, 2003.
DOI : 10.1136/ard.62.2.127

E. Ç?nar, Y. Akkoç, and H. Karapolat, Postural deformities: potential morbidities to cause balance problems in patients with ankylosing spondylitis?, European Journal of Rheumatology, vol.3, issue.1, pp.5-9, 2016.
DOI : 10.5152/eurjrheum.2015.15104

C. Stolwijk, M. Pierik, and R. Landewé, Prevalence of Self-Reported Spondyloarthritis Features in a Cohort of Patients with Inflammatory Bowel Disease, Canadian Journal of Gastroenterology, vol.27, issue.4, pp.199-205, 2013.
DOI : 10.1155/2013/139702

K. Kamo, T. Shuto, and A. Haraguchi, Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey, Modern Rheumatology, vol.40, issue.7, pp.435-437, 2015.
DOI : 10.3899/jrheum.121029

L. Hamilton, A. Macgregor, and D. Newman, Validation of a Patient Self-Reported Screening Questionnaire for Axial Spondyloarthropathy in a UK Population, Spine, vol.38, issue.6, pp.502-506, 2013.
DOI : 10.1097/BRS.0b013e318273aa4f

L. Van-praet, F. Van-den-bosch, and H. Mielants, Mucosal Inflammation in Spondylarthritides: Past, Present, and Future, Current Rheumatology Reports, vol.25, issue.10, pp.409-415, 2011.
DOI : 10.1002/art.24899

M. Fantini, F. Pallone, and G. Monteleone, Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies, World Journal of Gastroenterology, vol.15, issue.20, pp.2472-2478, 2009.
DOI : 10.3748/wjg.15.2472

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686905/pdf

H. Mielants, E. Veys, and C. Cuvelier, Ileocolonoscopic Findings in Seronegative Spondylarthropathies, Rheumatology, vol.XXVII, issue.suppl 2, pp.95-105, 1988.
DOI : 10.1093/rheumatology/XXVII.suppl_2.95

M. Dougados, M. Alemanni, and M. Tulliez, Systematic ileocolonoscopy in seronegative spondylarthropathies], Rev Rhum Mal Osteoartic, vol.54, pp.279-283, 1987.

B. Thjodleifsson, A. Geirsson, and S. Björnsson, A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland, Arthritis & Rheumatism, vol.48, issue.8
DOI : 10.1016/0016-5085(89)91557-6

M. Leirisalo-repo, U. Turunen, and S. Stenman, High Frequency of Silent Inflammatory Bowel Disease in Spondylarthropathy, Arthritis & Rheumatism, vol.296, issue.1, pp.23-31, 1994.
DOI : 10.7326/0003-4819-105-6-883

W. Chey, J. Kurlander, and S. Eswaran, Irritable Bowel Syndrome, JAMA, vol.313, issue.9
DOI : 10.1001/jama.2015.0954

A. Zohar, A. Cohen, and H. Bitterman, Gastrointestinal comorbidities in patients with psoriatic arthritis, Clinical Rheumatology, vol.34, issue.11, pp.2679-2684, 2016.
DOI : 10.1007/s00296-014-2955-9

R. Et-hépato-gastro, Entérologie ayant pour objectif de dépister les manifestations ostéo-articulaires associées aux maladies inflammatoires chroniques de l'intestin

. Acceptez-vous, au travers de ce questionnaire, la participation à ce travail ? OUI NON Vous êtes libre de vous retirer à tout moment